The following safety information is necessary for those who prescribes or is prescribed to take generic Risperdal as antipsychotic medication.
First of all, Risperdal (Risperidone) is not approved for the treatment of patients with Dementia-Related Psychosis. Such elderly patients treated with atypical antipsychotic drugs are at an increased risk of death.
Second, Risperdal [...]
ABILIFY (Aripiprazole) drug was developed by two companies: Otsuka Pharmaceutical Co., Ltd and Bristol-Myers Squibb Company. In 2004 Abilify medicine was approved in for treating schizophrenia disease and in 2008 it was ratified as medicine for bipolar disorder.
It has been known today that the U.S. Food and Drug Administration (FDA) [...]
Professor Eduard Vieta, Clinical Institute of Neuroscience, University of Barcelona, Spain suggests that bipolar disorder is considered to be a chronic, lifelong illness. Patients can become depressed or manic. And it is generally agreed that maintenance therapy is important and can give long-term relief from the relapses.
The data from [...]
Risperdal drug (Risperidone) is an oral prescription medication that has been approved in the UK for the treatment of mania in bipolar disorder, also known as manic-depression. It causes periods of extreme depression and mania and leads to unusual shifts in a person’s energy, mood and ability to function. This chronic [...]
Abilify drug was generally approved in 2004 for treating schizophrenia disease and this medicine was supposed to be used in treating bipolar disorder. Indeed, on April 8, 2008, the European Commission allowed Abilify medication (Aripiprazole) to be marketed for patients with Bipolar I Disorder.
Such kind of disease as Bipolar I Disorder contains [...]
According to new facts of Value in Health, the newer antipsychotic Zyprexa (Olanzapine) may not result in cost savings comparing with an older, inexpensive generic antipsychotic in treating of schizophrenia disease. It was revealed that despite higher medication costs of Zyprexa tablets the difference in one-year direct total costs between this [...]
Abilify antipsychotic medicine was introduced in 2002 as the first and only dopamine partial agonist. It is generally prescribed for the treatment of schizophrenia disease and acute manic and mixed episodes associated with bipolar disorder.
It has been known today that the US Food and Drug Administration (FDA) approved an oral [...]
